Study on prevention of severe oral mucositis for head and neck cancer patients with radiotherapy

Study on prevention of severe oral mucositis for head and neck cancer patients with radiotherapy - Study on prevention of severe oral mucositis for head and neck cancer patients with radiotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028813

Enrollment

Registered

2017-09-01

Start date

2017-09-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

head and neck cancer

Interventions

When grade 1 oral mucositis develops, apply Lindelon VG ointment dissolved with olive oil. The application should be four times a day, after breakfast, after lunch, after dinner, before going to bed.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Gender: no questions Hospitalization / outpatient: no question

Exclusion criteria

Exclusion criteria: Patient who is difficult to visit Nagasaki University Hospital Perioperative Oral Administration Center after treatment. Patients with radiation dose of 50 Gy or less.

Design outcomes

Primary

Measure	Time frame
Grade 3 Incidence of severe oral mucositis	—

Secondary

Measure	Time frame
Completion rate of CRT and BRT	—

Countries

Japan

Contacts

Public ContactSakiko Soutome

Nagasaki University Hospital Perioperative Oral Management Center

sakiko@nagasaki-u.ac.jp095-819-7698

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026